Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy

Konstantinos Charizanis, Kuang Yung Lee, Ranjan Batra, Marianne Goodwin, Chaolin Zhang, Yuan Yuan, Lily Shiue, Melissa Cline, Marina M. Scotti, Guangbin Xia, Ashok Kumar, Tetsuo Ashizawa, H. Brent Clark, Takashi Kimura, Masanori P. Takahashi, Harutoshi Fujimura, Kenji Jinnai, Hiroo Yoshikawa, Mário Gomes-Pereira, Geneviève GourdonNoriaki Sakai, Seiji Nishino, Thomas C. Foster, Manuel Ares, Robert B. Darnell, Maurice S. Swanson

Research output: Contribution to journalArticlepeer-review

260 Scopus citations


The RNA-mediated disease model for myotonic dystrophy (DM) proposes that microsatellite C(C)TG expansions express toxic RNAs that disrupt splicing regulation by altering MBNL1 and CELF1 activities. While this model explains DM manifestations in muscle, less is known about the effects of C(C)UG expression on the brain. Here, we report that Mbnl2 knockout mice develop several DM-associated central nervous system (CNS) features including abnormal REM sleep propensity and deficits in spatial memory. Mbnl2 is prominently expressed in the hippocampus and Mbnl2 knockouts show a decrease in NMDA receptor (NMDAR) synaptic transmission and impaired hippocampal synaptic plasticity. While Mbnl2 loss did not significantly alter target transcript levels in the hippocampus, misregulated splicing of hundreds of exons was detected using splicing microarrays, RNA-seq, and HITS-CLIP. Importantly, the majority of the Mbnl2-regulated exons examined were similarly misregulated in DM. We propose that major pathological features of the DM brain result from disruption of the MBNL2-mediated developmental splicing program.

Original languageEnglish (US)
Pages (from-to)437-450
Number of pages14
Issue number3
StatePublished - Aug 9 2012

Bibliographical note

Funding Information:
The authors thank C. Thornton for Mbnl2 GT4 mice, L. Ranum for manuscript comments, and the Research Resource Network Japan for human brain samples. This work was supported by grants from the NIH (NS058901 to M.S.S; K99GM95713 to C.Z.; NS34389 to R.B.D.; GM084317 to M.A.; and AG014979, AG037984, and AG036800 to T.C.F.), the McKnight Brain Research Foundation (T.C.F.), the MDA (4280 to M.S.S., 135140 to M.A.), the NCNP Japan (22-7 to K.J.), and the Japanese Ministry of Health, Labour, and Welfare (22-118 to T.K.).


Dive into the research topics of 'Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy'. Together they form a unique fingerprint.

Cite this